evt | News | May 29, 2019
Study Compares Different Sizes of Microspheres for Embolization to Treat BPH
May 30, 2019—Results of a single-center study comparing the safety and efficacy of prostatic artery embolization (PAE) using trisacryl gelatin microspheres of different sizes for treatment of benign prostatic hyperplasia (BPH) were published by Daniel Torres, MD, et al in Journal of Vascular and Interventional Radiology (JVIR; 2019;30:638–644).
evt | News | September 4, 2018
Embolx's Next-Generation Sniper Balloon Occlusion Microcatheters Approved in Europe
September 5, 2018—Embolx, Inc., which develops microcatheters for arterial embolization procedures, announced CE Mark certifications for its next-generation Sniper balloon occlusion microcatheters designed to deliver pressure-directed arterial embolization therapy to treat cancerous tumors, enlarged prostate, and uterine fibroids.
evt | Article | April 2020
evt | News | December 16, 2019
Randomized, Sham-Controlled Trial Demonstrates Efficacy of Prostate Artery Embolization for Symptomatic BPH
December 16, 2019—A study published online ahead of print in European Urology evaluating prostatic artery embolization (PAE) for symptomatic benign prostatic hyperplasia (BPH) found that the “clearly superior efficacy” of PAE compared with a sham procedure supports the use of PAE in patients with typical symptoms associated with BPH.